Subscribe
Israel-Hamas Conflict
US Politics
Hurricanes
Republican Party
Donald Trump
US Presidential Election
Election Day
Fox News
US Economy
Kamala Harris
US Crime
Halloween
NFL
Published

Biogen is buying up an immune drug developer for $1.8 billion

Summary by Quartz
Biotechnology giant Biogen said on Wednesday that it is acquiring immune drug developer Human Immunology Biosciences (HI-Bio) to boost its late-stage pipeline and immunology portfolio. Biogen has agreed to a $1.15 billion upfront payment and up to $650 million in additional payments if certain milestones are met.Read more...
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cambridge, MassachusettsCambridge, Massachusetts

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal